SBP solbec pharmaceuticals limited

pharma deal, page-3

  1. 5,996 Posts.
    lightbulb Created with Sketch. 162
    So Coleys CPG 'toll like receptor9' agonist ProMune has just been licensed out to Pfizer in a deal worth more than 1/2 billion dollars in payments plus royalties on top of that . ProMune , combined with 2 front line chemos , demonstrated they are almost as good as RTs BEC (Coramsine) NSCLC response results as a stand alone treatment . At what point I wonder does Solbec become worth more than 20m ?
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.